Log in to save to my catalogue

Consequences and therapy of the metabolic acidosis of chronic kidney disease

Consequences and therapy of the metabolic acidosis of chronic kidney disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2991191

Consequences and therapy of the metabolic acidosis of chronic kidney disease

About this item

Full title

Consequences and therapy of the metabolic acidosis of chronic kidney disease

Publisher

Berlin/Heidelberg: Springer-Verlag

Journal title

Pediatric nephrology (Berlin, West), 2011-01, Vol.26 (1), p.19-28

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer-Verlag

More information

Scope and Contents

Contents

Metabolic acidosis is common in patients with chronic kidney disease (CKD), particularly once the glomerular filtration rate (GFR) falls below 25 ml/min/1.73 m
2
. It is usually mild to moderate in magnitude with the serum bicarbonate concentration ([HCO
3

]) ranging from 12 to 23 mEq/l. Even so, it can have substantial adverse eff...

Alternative Titles

Full title

Consequences and therapy of the metabolic acidosis of chronic kidney disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2991191

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2991191

Other Identifiers

ISSN

0931-041X

E-ISSN

1432-198X

DOI

10.1007/s00467-010-1564-4

How to access this item